Hot Products
| Catalog No. | Information |
| CFN90550 | L-Arginine L-Arginine is the nitrogen donor for synthesis of nitric oxide, a potent vasodilator that is deficient during times of sickle cell crisis. L-Arginine exhibits anti-atherosclerotic effect, L-arginine and soy enriched diet are effective in prevention of osteoporosis associated with diabetes mellitus. Exogenous L-Arginine could enhance neonate lymphocyte proliferation through an interleukin-2-independent pathway. |
| CFN98324 | Lariciresinol Lariciresinol is an enterolignan precursor, it possesses fungicidal activities by disrupting the fungal plasma membrane and therapeutic potential as a novel antifungal agent for the treatment of fungal infectious diseases in humans. Dietary lariciresinol can attenuate mammary tumor growth and reduce blood vessel density in human MCF-7 breast cancer xenografts and carcinogen-induced mammary tumors in rats. |
| CFN95400 | Lariciresinol 4'-O-glucoside |
| CFN95389 | Lariciresinol 4-O-glucoside |
| CFN97679 | Lariciresinol acetate Reference standards. |
| CFN70400 | Laricitrin Laricitrin is a novel flavonoid ABCG2 inhibitor, it suppresses certain factors and decreases the progression of lung cancer cells that are promoted by BaP in the lung cancer tumor microenvironment. Laricitrin could be an efficacious immunoadjuvant and have a synergistic effect when combined with chemotherapy. |
| CFN80175 | Laricitrin 3-O-glucoside Laricitrin 3-O-glucoside has antioxidant property. |
| CFN00289 | Lasiocarpine Lasiocarpine has antimitotic action,it has hepatocarcinogenicity, the effect can be better explained by its strong selection (promotion) influence on initiated hepatocytes, rather than by its very weak initiating activity. |
| CFN00290 | Lasiocarpine N-oxide Lasiocarpine-N-oxide shows antimicrobial activity against selected pathogenic bacteria and fungi. |
| CFN70188 | L-Asparagine L-asparaginase is effective in suppressing cellular immunity and inducing remission in patients with acute lymphocytic leukemia, mainly a non-B-cell disease.The enhancing action of L-asparagine upon insulin release evoked by L-leucine is attributable to an increased generation rate of cytosolic NADPH rather than any increase in nutrients oxidation. |
